Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 859.00
-0.90 (-0.10%)
Jul 31, 2026, 3:29 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 17.7 billion as of July 31, 2026. Its market cap has decreased by -15.30% in one year.
Market Cap
17.70B
Enterprise Value
15.26B
Revenue
9.04B
Ranking
n/a
PE Ratio
27.53
Stock Price
859.00
ChartMarket Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 17.70B, an increase of 99.47%. That is a compound annual growth rate of 14.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 17.70B | 6.22% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 55.43B |
| Orchid Pharma | 50.79B |
| RPG Life Sciences | 47.14B |
| Solara Active Pharma Sciences | 24.39B |
| Beta Drugs | 22.54B |
| Indoco Remedies | 20.77B |
| Ind-Swift Laboratories | 19.39B |
| Sakar Healthcare | 18.91B |